Synapse - Weinberg Fellows

Results (77)

Efficacy and safety of cabozantinib (CABO) for advanced Grade 3 (G3) neuroendocrine tumours (NETs) after progression on prior therapy: Subgroup analysis of the phase III CABINET trial (Alliance A021602)

Meeting Abstract

Strosberg, J.; Zemla, T.; Geyer, S.; Pulsipher, S.; Behr, S.; Raj, N.; Vijayvergia, N.; Dasari, A.; Meyerhardt, J.; Wolin, E.; more...
Journal of Neuroendocrinology (2025)

Fulltext@MSK | Save

Pancreatic neuroendocrine tumours (pNET) and MUTYH germline (GPV) and somatic (SPV) pathogenic variants: A multinational study

Meeting Abstract

Riechelmann, R.; Torrezan, G. T.; Cingarlini, S.; Raj, N.; Bergsland, E.; Strosberg, J.; Trevisani, E.; Moon, F.; Felismino, T. C.; Knappskog, S.; more...
Journal of Neuroendocrinology (2025)

Fulltext@MSK | Save

Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival

Journal Article

Cooper, A. J.; Garbo, E.; Arfe, A.; Conroy, M.; Shaverdian, N.; Bott, M.; Gorria, T.; Pecci, F.; Aldea, M.; Anagnostou, V.; more...
Cancer (2025)

Fulltext@MSK | Save

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

Journal Article

Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
Cancer (2025)

Fulltext@MSK | Save

Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours

Research Letter

Gold, S. A.; Yu, R.; Jayalath, V. H.; Baky, F.; Liso, N.; Williams, B.; Tin, A. L.; Feldman, D. R.; Funt, S. A.; Vickers, A. J.; more...
BJU International (2025)

Fulltext@MSK | Save

Top advances of the year: Neoadjuvant immunotherapy in melanoma

Editorial

Chen, M. F.; Postow, M. A.
Cancer (2025)

Fulltext@MSK | Save

Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2– early breast cancer

Journal Article

Graff, S. L.; Tolaney, S. M.; Hart, L. L.; Razavi, P.; Janni, W.; Schwartzberg, L. S.; Danyliv, A.; Akdere, M.; Ferrusi, I.; Adhikary, R. R.; more...
Cancer (2025)

Fulltext@MSK | Save

Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer

Journal Article

Patel, R. V.; Bowden, J. M.; Boselli, D.; Strahley, A. E.; Gibbs, S. E. L.; Murali, K. P.; Patel, V. R.; Kotecha, R. R.; Nelson, J. E.
Cancer (2025)

Fulltext@MSK | Save

Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes

Research Letter

Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
Journal of the European Academy of Dermatology and Venereology (2025)

Fulltext@MSK | Save

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3–targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer

Review

Sands, J. M.; Champiat, S.; Hummel, H. D.; Paulson, K. G.; Borghaei, H.; Alvarez, J. B.; Carbone, D. P.; Carlisle, J. W.; Choudhury, N. J.; Clarke, J. M.; more...
Cancer (2025)

Fulltext@MSK | Save